overview
Chronic rhinosinusitis (CRS) is a long-term inflammatory condition that affects the sinuses and nasal passages. It causes symptoms such as nasal congestion, facial pain, loss of smell, and thick nasal discharge that last for 12 weeks or longer. CRS is generally classified into two major types: chronic rhinosinusitis with nasal polyps (CRSwNP) and chronic rhinosinusitis without nasal polyps (CRSsNP). Recent research has revealed that women are more likely than men to develop CRSsNP, suggesting that biological, hormonal, and environmental factors may play significant roles in this difference.
Understanding Chronic Rhinosinusitis
CRS affects millions of people worldwide and significantly reduces quality of life. It can interfere with sleep, productivity, and emotional well-being. The condition occurs when the lining of the sinuses becomes persistently inflamed, leading to blocked nasal passages and mucus buildup. While the exact cause is not fully understood, contributing factors include allergies, infections, structural abnormalities, and immune system dysfunction.
The two subtypes of CRS differ not only in their physical presentation but also in their underlying mechanisms. CRSwNP is characterized by soft, noncancerous growths (polyps) in the nasal passages, often associated with type 2 inflammation and elevated levels of eosinophils. CRSsNP, on the other hand, involves inflammation without polyp formation and tends to show a different immune response pattern.
Why Women Are at Higher Risk
Several studies have shown that women are more likely than men to develop CRSsNP. One explanation lies in hormonal differences. Female sex hormones, particularly estrogen and progesterone, can influence immune responses and mucosal inflammation in the respiratory tract. These hormones may alter the way the body reacts to environmental irritants, allergens, or infections, increasing the risk of chronic sinus inflammation.
In addition, women often have stronger immune responses compared to men. While this heightened immunity can help fight infections more effectively, it may also make women more prone to inflammatory and autoimmune diseases. CRS, especially the non-polyp form, may be another example of this pattern.
Environmental and lifestyle factors may also contribute. Women are more likely to seek medical care and receive a diagnosis for chronic sinus issues, which might lead to higher reported rates. However, even after adjusting for healthcare-seeking behavior, studies suggest a genuine biological difference rather than just reporting bias.
Clinical Implications
Recognizing that women are more likely to develop CRSsNP has important implications for diagnosis and treatment. Because symptoms can overlap with other conditions such as allergies or migraine-related sinus pain, doctors must perform careful evaluations. Nasal endoscopy and imaging studies can help confirm the diagnosis and rule out other causes.
Treatment for CRSsNP typically includes nasal corticosteroids, saline irrigation, and antibiotics if a bacterial infection is present. In severe or resistant cases, endoscopic sinus surgery may be considered to restore sinus drainage and ventilation. However, since the underlying inflammation differs between CRSsNP and CRSwNP, therapies targeting immune pathways specific to CRSsNP are under investigation.
Conclusion
In summary, women appear to have higher odds of developing chronic rhinosinusitis without nasal polyps compared to men, likely due to a combination of hormonal influences, immune system differences, and environmental factors. Continued research is needed to fully understand these mechanisms and to develop more effective, individualized treatment strategies. Recognizing gender differences in sinus disease is a crucial step toward better prevention, management, and quality of life for those affected by this chronic condition.
